Seeking Alpha

NPS Pharmaceuticals (NPSP -3.7%) gives back all its premarket gains and more, despite the...

NPS Pharmaceuticals (NPSP -3.7%) gives back all its premarket gains and more, despite the postive Phase 3 results for its hypoparathyroid treatment earlier today. The company has been on a steady downtrend for most of this year, losing nearly 50% since hitting a 52-week high in May.
Comments (1)
  • NPSP seems like a very good buy at this point. It doesn't seem to have anywhere to go but up. The market can of course be tricky but I see a 90% chance of making a profit here.
    8 Nov 2011, 07:47 AM Reply Like
DJIA (DIA) S&P 500 (SPY)